Consensus $8.69. Raises FY23 revenue view to $9.12B-$9.22B from $8.93B-$9.08B, consensus $9.06B. Sees FY23 capital expenditures $40M. Sees FY23 cash provided by operations $1.3B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DGX:
- Quest (NYSE:DGX) Stock Down Despite Beating Q2 Estimates
- Quest Diagnostics Reports Second Quarter 2023 Financial Results; Updates Guidance for Full Year 2023
- Notable companies reporting before tomorrow’s open
- DGX Earnings this Week: How Will it Perform?
- Quest Diagnostics launches novel prostate cancer test